Your browser doesn't support javascript.
loading
[A global core outcome measurement set for snakebite clinical trials]. / Définition d'un jeu universel de critères de décision de base pour les essais cliniques sur les morsures de serpent.
Abouyannis, Michael; Esmail, Hanif; Hamaluba, Mainga; Ngama, Mwanajuma; Mwangudzah, Hope; Mumba, Noni; Yeri, Betty K; Mwalukore, Salim; Alphan, Hassan J; Aggarwal, Dinesh; Alcoba, Gabriel; Cammack, Nick; Chippaux, Jean-Philippe; Coldiron, Matthew E; Gutiérrez, José M; Habib, Abdulrazaq G; Harrison, Robert A; Isbister, Geoffrey K; Lavonas, Eric J; Martins, Diogo; Ribeiro, Isabela; Watson, James A; Williams, David J; Casewell, Nicholas R; Walker, Sarah A; Lalloo, David G.
Afiliação
  • Abouyannis M; Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, Royaume-Uni.
  • Esmail H; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Hamaluba M; Medical Research Council Clinical Trials Unit at UCL, University College London, Londres, Royaume-Uni.
  • Ngama M; Institute for Global Health, University College London, Londres, Royaume-Uni.
  • Mwangudzah H; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Mumba N; Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, Oxford, Royaume-Uni.
  • Yeri BK; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Mwalukore S; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Alphan HJ; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Aggarwal D; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Alcoba G; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Cammack N; Kenya Medical Research Institute (KEMRI) - Wellcome Research Programme, Kilifi, Kenya.
  • Chippaux JP; Department of Medicine, University of Cambridge, Royaume-Uni.
  • Coldiron ME; Service de médecine, Médecins Sans Frontières, Genève, Suisse.
  • Gutiérrez JM; Service de médecine tropicale et humanitaire, Hôpitaux universitaires de Genève, Genève, Suisse.
  • Habib AG; Wellcome Trust, Londres, Royaume-Uni.
  • Harrison RA; Université Paris Cité, Institut de Recherche pour le Développement (IRD), Unité « Mère et enfant en milieu tropical : pathogènes, système de santé et transition épidémiologique ¼ (MERIT), Paris, France.
  • Isbister GK; Epicentre, Paris, France.
  • Lavonas EJ; Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
  • Martins D; Bayero University Department of Infectious and Tropical Diseases, Kano, Nigéria.
  • Ribeiro I; Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, Royaume-Uni.
  • Watson JA; Clinical Toxicology Research Group, University of Newcastle, Newcastle, NSW, Australie.
  • Williams DJ; Department of Emergency Medicine, Denver Health and Hospital Authority, Denver, Colorado; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, États-Unis.
  • Casewell NR; Wellcome Trust, Londres, Royaume-Uni.
  • Walker SA; Drugs for Neglected Diseases Initiative, Genève, Suisse.
  • Lalloo DG; Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, Oxford, Royaume-Uni.
Med Trop Sante Int ; 3(3)2023 09 30.
Article em Fr | MEDLINE | ID: mdl-38094484
ABSTRACT

Background:

Snakebite clinical trials have often used heterogeneous outcome measures and there is an urgent need for standardisation.

Method:

A globally representative group of key stakeholders came together to reach consensus on a globally relevant set of core outcome measurements. Outcome domains and outcome measurement instruments were identified through searching the literature and a systematic review of snakebite clinical trials. Outcome domains were shortlisted by use of a questionnaire and consensus was reached among stakeholders and the patient group through facilitated discussions and voting.

Results:

Five universal core outcome measures should be included in all future snakebite clinical trials mortality, WHO disability assessment scale, patient-specific functional scale, acute allergic reaction by Brown criteria, and serum sickness by formal criteria. Additional syndrome-specific core outcome measures should be used depending on the biting species.

Conclusion:

This core outcome measurement set provides global standardisation, supports the priorities of patients and clinicians, enables meta-analysis, and is appropriate for use in low-income and middle-income settings.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mordeduras de Serpentes / Ensaios Clínicos como Assunto Limite: Humans Idioma: Fr Revista: Med Trop Sante Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mordeduras de Serpentes / Ensaios Clínicos como Assunto Limite: Humans Idioma: Fr Revista: Med Trop Sante Int Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido